Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination

Nutrients, Free Full-Text

Multiplex Assays for COVID-19 (SARS-CoV-2) Research Applications

Dextrin, C18H32O16

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

Microbiota I-Center (MagIC) (香港微生物菌群創新中心) on LinkedIn: #covid #gut # microbiota #microbiome #sim01 #cuhk #cumedicine #covid19

Synbiotic formula shows promise in reducing long COVID symptoms

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases

Frontiers Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease

Synbiotics - Food